Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy.

Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy. Blood. 2009 Mar 05; 113(10):2172-80.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.